COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 208 filers reported holding COHERUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $248,241 | -36.5% | 58,136 | +1.7% | 0.00% | -50.0% |
| Q1 2023 | $391,111 | +114259.9% | 57,180 | +32.5% | 0.00% | -20.0% |
| Q4 2022 | $342 | -99.9% | 43,151 | -6.6% | 0.01% | -28.6% |
| Q3 2022 | $444,000 | +32.9% | 46,190 | +0.2% | 0.01% | +40.0% |
| Q2 2022 | $334,000 | -42.7% | 46,115 | +2.1% | 0.01% | -37.5% |
| Q1 2022 | $583,000 | -20.5% | 45,183 | -1.7% | 0.01% | -11.1% |
| Q4 2021 | $733,000 | -2.9% | 45,949 | -2.1% | 0.01% | 0.0% |
| Q3 2021 | $755,000 | +9.9% | 46,957 | -5.5% | 0.01% | +12.5% |
| Q2 2021 | $687,000 | -1.7% | 49,678 | +3.8% | 0.01% | -11.1% |
| Q1 2021 | $699,000 | -21.0% | 47,858 | -6.0% | 0.01% | -18.2% |
| Q4 2020 | $885,000 | -17.8% | 50,909 | -13.3% | 0.01% | -26.7% |
| Q3 2020 | $1,077,000 | +25.1% | 58,748 | +21.9% | 0.02% | +7.1% |
| Q2 2020 | $861,000 | – | 48,183 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |